Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques

Cardiovascular Research

Volumn 43, Issue 3, 1999, Pages 744-754

  Cromheeke, Kristel M ^a   Kockx, Mark M ^b   De Meyer, Guido R Y ^c   Bosmans, Johan M ^a   Bult, Hidde ^c   Beelaerts, Walter J F ^b   Vrints, Chris J ^a   Herman, Arnold G ^c  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b MIDDELHEIM HOSPITAL   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Atherosclerosis; Cholesterol; Macrophages; Nitric oxide; Platelets

Indexed keywords

3 NITROTYROSINE; CEROID; LIPOPROTEIN; NITRIC OXIDE SYNTHASE;

ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; LIPID OXIDATION; LIPID PEROXIDATION; MACROPHAGE; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER;

AGED; ANALYSIS OF VARIANCE; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CAROTID ARTERIES; CEROID; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MACROPHAGES; MALE; MICROSCOPY, ELECTRON; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TYROSINE;

EID: 0033566868     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00148-0     Document Type: Article

References (39)

1. Ball R.Y., Carpenter K.L.H., Mitchinson M.J. What is the significance of ceroid in human atherosclerosis? Arch Pathol Lab Med. 111:1987;1134-1140.
2. Györky F., Shimanura T., O'Neal R.M. The fine structure of ceroid in human atheroma. J Histochem Cytochem. 15:1968;732-736.
3. Mitchinson M.J., Hothersall D.C., Brooks P.N., De Burbure C.Y. The distribution of ceroid in human atherosclerosis. J Pathol. 145:1985;177-183.
4. Buttery L.D.K., Springall D.R., Chester A.H., et al. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 75:1996;77-85.
5. Wilcox J.N., Subramanian R.R., Sundell C.L., et al. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol. 17:1997;2479-2488.
6. Luoma J.S., Strålin P., Marklund S.L., et al. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions. Colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol. 18:1998;157-167.
7. Esaki T., Hayashi T., Muto E., et al. Expression of inducible nitric oxide synthase in T-lymphocytes and macrophages of cholesterol-fed rabbits. Atherosclerosis. 128:1997;39-46.
8. Bult H. Nitric oxide and atherosclerosis: possible implications for therapy. Mol Med Today. 2:1996;510-518.
9. Moore K.P., Darley-Usmar V., Morrow J., Roberts L.J. Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ Res. 77:1995;335-341.
10. Darley-Usmar V.M., Hogg N., O'Leary V.J., Wilson M.T., Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun. 17:1992;9-20.
11. Ischiropoulos H., Zhu L., Beckman J.S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys. 298:(1):1992;446-451.
12. Beckmann J.S., Ye Y.Z., Anderson P.G., et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler. 375:1994;81-88.
13. Kockx M.M., De Meyer G.R.Y., Muhring J., et al. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 97:1998;2307-2315.
14. Stary H.C., Blankenhorn D.H., Chandler B., et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions. Circulation. 85:1992;391-405.
15. Stary H.C., Chandler B., Glagov S., et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. Circulation. 98:1994;2462-2478.
16. Stary H.C., Chandler B., Dinsmore R.E., et al. A definition of advanced types of atherosclerotic lesion and a histological classification of atherosclerosis. Circulation. 92:1995;1355-1374.
17. Wissler R.W., Hiltscher L., Oinuma T. Atherosclerosis and coronary artery disease. 1:1996;475-489. Ch. 27.
18. Kockx M.M., Muhring J., Knaapen M.W.M., De Meyer G.R.Y. RNA synthesis and splicing interferes with DNA in situ-end labeling techniques used to detect apoptosis. Am J Path. 152:1998;885-888.
19. Kockx M.M., De Meyer G.R.Y., Andries L.J., et al. The endothelium during cuff-induced neointima formation in the rabbit carotid artery. Arterioscler Thromb. 13:1993;1874-1884.
20. Vouldoukis I., Riveros-Morena V., Dugas B., et al. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc Natl Acad Sci USA. 92:1995;7804-7808.
21. Komminoth P., Adams V., Long A.A., et al. Evaluation of methods for hepatitis C virus detection in archival liver biopsies. Comparison of histology, immunohistochemistry, in-situ hybridization, reverse transcriptase polymerase chain reaction (RT-PCR). Pathol Res Pract. 190:1994;1017-1025.
22. Katzuda S., Boyd H.C., Fligner C., Ross R., Gown A.M. Human atherosclerosis III Immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol. 140:1992;907-914.
23. Sakuma T., Monma N., Satodate R., et al. Ceroid pigment deposition in circulating blood monocytes and T lymphocytes in Hermansky-Pudlak syndrome: An ultrastructural study. Pathol Inter. 45:1995;866-870.
24. White C.R., Brock T.A., Chang L.Y., et al. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA. 91:1994;1044-1048.
25. Daugherty A., Dunn J.L., Rateri D.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 94:(1):1994;437-444.
26. Panasenko O.M., Briviba K., Klotz L.O., Sies H. Oxidative modification and nitration of human low-density lipoproteins by the reaction of hypochlorous acid with nitrite. Arch Biochem Biophys. 15:1997;254-259.
27. Briggs R.T., Karnovsky M.L., Karnovsky M.J. Hydrogen peroxide production in chronic granulomatous disease. J Clin Invest. 59:1977;1088-1098.
28. Ishihara T., Akizuki S., Yokota T., et al. Foamy cells associated with platelet phagocytosis. Am J Pathol. 114:1984;104-111.
29. Lee F.-Y., Lee T.-S., Pan C.-C., Huang A.-L., Chau L.-Y. Colocalization of iron and ceroid in human atherosclerotic lesions. Atherosclerosis. 138:1998;281-288.
30. Yuan X.-M., Brunk U.T., Olsson A.G. Effects of iron- and hemoglobin-loaded human monocyte-derived macrophages on oxidation and uptake of LDL. Arterioscler Thromb Vasc Biol. 15:1995;1345-1351.
31. Sambrano G.R., Parthasarathy S., Steinberg D. Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. Proc Natl Acad Sci USA. 91:1994;3265-3269.
32. Geng Y.J., Petersson A.S., Wennmalm A., Hansson G.K. Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells. Exp Cell Res. 214:1994;418-428.
33. Hecker M., Preiss C., Schini-Kerth V.B., Busse R. Antioxidants differentially affect nuclear factor kappa B-mediated nitric oxide synthase expression in vascular smooth muscle cells. FEBS Lett. 380:1996;224-228.
34. Matthys K.E., Jorens P.G., Marescau B., et al. Oxidized lipoproteins suppress nitric oxide synthase in macrophages: study of glucocorticoid receptor involvement. Med Inflammat. 3:1994;323-327.
35. Jorens P.G., Matthys K.E., Bult H. Modulation of nitric oxide synthase activity in macrophages. Mediators Inflamm. 4:1995;75-89.
36. Nozaki Y., Hasegawa Y., Ichiyama S., Nakashima I., Shimokata K. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect Immun. 65:1997;3644-3647.
37. Moilanen E., Moilanen T., Knowles R., et al. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol. 150:1997;881-887.
38. Murrell G.A.C., Jang D., Williams R.J. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun. 206:1995;15-21.
39. Kockx M.M., De Meyer G.R.Y., Bortier H., et al. Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. Circulation. 94:1996;1255-1262.